Cessatech A/S Logo

Cessatech A/S

CESSA | SPGR

Overview

Corporate Details

ISIN(s):
DK0061411964
LEI:
549300WO5SKVXWPOXR16
Country:
Denmark
Address:
Kanonbådsvej 2, 1437 København K
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Cessatech A/S is a clinical-stage pharmaceutical company specializing in the research and development of pain relief treatments for children. A spinout from Copenhagen University Hospital, Rigshospitalet, the company focuses on addressing unmet medical needs in pediatric care. Its lead asset, CT001, is a non-invasive analgesic nasal spray designed for children aged 1-17 experiencing acute pain or pain related to medical procedures. Cessatech's business model involves identifying and developing drugs with proven efficacy in adults for pediatric applications, aiming for a potentially shorter and de-risked development pathway. The company is managed by a team with extensive experience in drug development, pediatric research, and product launches.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Cessatech A/S. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cessatech A/S filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Cessatech A/S via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Lidds AB Logo
Develops a drug delivery platform for local, sustained-release oncology treatments.
Sweden LIDDS
Lineage Cell Therapeutics Inc. Logo
Developing off-the-shelf cell therapies to restore function in neurological & retinal diseases.
Israel LCTX
Lipidor AB Logo
Develops topical skin disease drugs using a lipid-based drug delivery platform.
Sweden LIPI
Lipigon Pharmaceuticals AB Logo
Develops RNA and small-molecule drugs for rare, lipid-related disorders.
Sweden LPGO
Lipum AB Logo
Develops novel antibody therapies for chronic inflammatory diseases like rheumatoid arthritis.
Sweden LIPUM
LYSOGENE Logo France LYS
Lytix Biopharma AS Logo
Develops oncolytic peptides that kill cancer cells and stimulate an anti-tumor immune response.
Norway LYTIX
Matricelf Ltd. Logo
Engineering autologous 3D tissue implants from patient cells to treat spinal cord injuries.
Israel MTLF
Mazaro N.V. Logo
Engineering patented, high-efficiency transmissions for vehicles and industrial drivelines.
Belgium MLMAZ
Medesis Pharma S.A. Logo
Biotech creating CNS and oncology therapies using a proprietary drug delivery platform.
France ALMDP